Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Observational Study of Venus P-Valve

NCT05835349 · tracked via the Priya Life Science Italy tracker
Sponsor
Venus MedTech (HangZhou) Inc
Phase
Observational
Started
2024-08-26
Last updated
2025-01-24

Condition(s) studied

Right Ventricular Outflow Tract Dysfunction

Investigational drug(s) / intervention(s)

transcatheter pulmonary valve implantation (TPVI)

transcatheter pulmonary valve implantation (TPVI): A stent-mounted valve is introduced over a guidewire and positioned in the RVOT, followed by balloon inflation to deploy the valve.

Study summary

Real-world evidence, retrospective and prospective, non-randomized, multicenter observational study of VenusP-ValveTM System in treating moderate or greater pulmonary regurgitation with/without pulmonary stenosis in patients with native right ventricular outflow tract (RVOT).

Eligibility

Sex
ALL
Min age
12 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria 1. Patients with native RVOT (including transvalvular patch repair) are present with moderate or greater pulmonary regurgitation with/without stenosis and are clinically indicated for pulmonary valve intervention. 2. The patient (or the patient's legally authorized representative) is willing to consent to participate in the study and will commit to completing all follow-up requirements. Exclusion Criteria: 1\. Patients with any condition contraindicated by the IFU or inability to comply with the Venus P-ValveTM System Instructions for Use or the study protocol.

Primary outcome measure(s)

  • Non-hierarchical composite endpoint — at six months
    * Freedom from VenusP-ValveTM (catheter or surgical) reintervention * Acceptable hemodynamic function, defined as: 1. Mild or less regurgitation measured by echocardiography; AND 2. Mean RVOT gradient as measured by echocardiography ≤35mmHg.

Trial sites (10)

FacilityCityRegionStatus
CHU Bordeaux Pessac New Aquitaine Not Yet Recruiting
Chu Nantes Nantes Pays de la Loire Region Recruiting
Marie Lannelongue Le Plessis-Robinson Île-de-France Region Recruiting
Hopital Necker-Enfants malades Paris Île-de-France Region Recruiting
Heart CenterMunich Munich Bavaria Not Yet Recruiting
Clinic of Congenital Heart Disease Berlin State of Berlin Not Yet Recruiting
OPBG Rome Rome Lazio Not Yet Recruiting
S. Donato Milan Milan Lombardy Not Yet Recruiting
Leeds General Infirmary Leeds England Not Yet Recruiting
Evelina Children's Hospital London England Not Yet Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05835349 on ClinicalTrials.gov ↗ ← All trials in Italy